Recalls / Active ingredient / Salmeterol Xinafoate
Salmeterol Xinafoate
3 FDA drug recalls involving the active ingredient “Salmeterol Xinafoate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-01-26 | Class II | Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation | CARDINAL HEALTHCARE |
| 2012-10-24 | Class III | Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173- | GlaxoSmithKline, LLC. |
| 2012-10-24 | Class III | Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuatio | GlaxoSmithKline, LLC. |